SUPERFICIAL BLADDER CANCER: THE ROLE OF INTERFERON-alpha

This publication has 61 references indexed in Scilit:

• Determination of Interferon-alpha Receptors in Urothelial Cancer and in Normal Urothelium
  Journal of Urology, 1997
• Evaluation of local immune response after intravesical bacille Calmette‐Guérin treatment for superficial bladder cancer
  British Journal of Urology, 1996
• A randomised prospective study comparing intravesical instillations of mitomycin-C, BCG-Tice, and BCG-RIVM in pTa-pT1 tumours and primary carcinoma in situ of the urinary bladder
  European Journal Of Cancer, 1993
• The immunomodulatory effects of urine from patients with superficial bladder cancer receiving intravesical evans BCG therapy
  Cancer Immunology, Immunotherapy, 1993
• Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer
  Cancer Immunology, Immunotherapy, 1992
• Immunomodulatory effect of interferon-α2b on natural killer cells and T lymphocytes from patients with transitional cell carcinoma of the bladder
  Anti-Cancer Drugs, 1992
• How Effective is Topical Alpha‐2b Interferon in Preventing Recurrence of Superficial Bladder Cancer?
  British Journal of Urology, 1991
• Clinical Studies on Cell‐mediated Immunity in Patients with Urinary Bladder Carcinoma: Blastogenic Response, Interleukin‐2 Production and Interferon‐y Production of Lymphocytes
  British Journal of Urology, 1990
• Intravesical treatment of bladder cancer with recombinant human interferon-β
  Cancer Immunology, Immunotherapy, 1989
• Interferon Therapy in Neoplastic Disease
  Acta Medica Scandinavica, 1978